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Abstract: In fluorescence guided surgery, data visualization represents a 
critical step between signal capture and display needed for clinical decisions 
informed by that signal. The diversity of methods for displaying surgical 
images are reviewed, and a particular focus is placed on electronically 
detected and visualized signals, as required for near-infrared or low 
concentration tracers. Factors driving the choices such as human perception, 
the need for rapid decision making in a surgical environment, and biases 
induced by display choices are outlined. Five practical suggestions are 
outlined for optimal display orientation, color map, transparency/alpha 
function, dynamic range compression, and color perception check. 
©2015 Optical Society of America 
OCIS codes: (170.1610) Clinical applications; (170.3880) Medical and biological imaging; 
(170.4730) Optical pathology; (260.2510) Fluorescence; (330.1730) Colorimetry; (330.5020) 
Perception psychology; 
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1. Introduction 
The goal of this review is to propose a set of best practices for presenting fluorescence-
derived information (emission intensity, concentration, ratiometric values, or receptor 
concentration) to the surgeon in an efficient manner that provides the full potential of 
fluorescence guided surgery (FGS) while minimizing interpretive error. Despite being a 
critical step in almost every FGS workflow, forming the link between the detection and 
characterization of biologically-relevant fluorescence markers and clinical action, data 
visualization in this context has not received adequate attention. Following a relevant 
description of the anatomical and neurophysiological basis for human vision and perceptual 
processing, four major topics are discussed: 1) color map representation of scalar 
measurements, 2) transparency functions for fusion of measurement data with white-light 
imaging, 3) real-time image compression for high dynamic range (12 – 22 bit) camera data, 
and 4) heads-up display visualization techniques. These form the basis for the conclusions 
which are highlighted thereafter. Finally, we introduce an open-source MATLAB-based 
graphical user interface (GUI) which can facilitate further investigation and implementation 
of these best practices. A rigorous and intentional focus on optimizing visualization methods 
will improve the interpretive value of FGS as a clinical procedure which will become more 
widely adopted. 
Modern intraoperative technology has allows a tremendous amount of information to be 
provided to the surgeon during a procedure—e.g., pre-operative MRI [1], CT [2], ultrasound 
[3] and PET [4] scans that are repeatedly viewed during the procedure and updated, 
intraoperative real-time tracking of surgical tools, haptic feedback from robotic manipulators 
[5]—for planning and navigation. Nevertheless, the actual resection of malignant tissue 
depends almost exclusively on the surgeon’s visual perception of the surgical field. Given the 
preeminence of vision in performing this task, there is reluctance to introduce any additional 
visual information that might obfuscate the colorimetric, textural, or contextual information 
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that is otherwise observed in the surgical field. Therefore, the majority of information that has 
entered the surgeon’s visual field as augmented reality has been targeted to the planning or 
post-resection verification stages. The advent of fluorescence guided surgery brings a stronger 
impetus for real-time intraoperative visualization, since this information is at the very least 
intrinsically coregistered and in many cases, can be directly visualized through an operating 
microscope with the use of a specialized illuminant. 
 
Fig. 1. (A) The number of publications in “fluorescence-guided surgery” or “fluorescence-
guided resection” in the past 25 years, showing the expotential growth in the field. (B) The 
Novadaq SPY Elite fluorescence imaging system, which has been at the forefront of the effort 
to expand fluorescence guided surgery capabilities, leading the commercial market. (C) 
Laproscopic images acquired under white-light and (D) by exciting indocyanine green which 
has been pseudocolored blue and overlaid onto C. (Source: Luigi Boni, MD [6]) showing a 
novel use of this for perfusion imaging of tissue. 
In specific applications, the introduction of this fluorescence-based exogenous visual 
information is becoming standard of care, exemplified by the adoption of 5-aminoleuvilenic 
acid-induced protophorphyrin IX [7] for glioma resection. Unlike some of the non-specific 
vascular optical tracers, ALA-induced PpIX has a high specificity for cancer cells [8], and has 
a demonstrated positive effect on extent of tumor resection. In addition, it emits light in the 
visible (red) part of the spectrum, which means it can be viewed naturally and turned on and 
off with the push of a button. The field of fluorescence guided surgery is relatively nascent 
compared with other image-guided technology, but is clearly in a boom stage of development 
(Fig. 1(A)). A myriad of new smart-targeted fluorophores are in various stages of pre-clinical 
investigation, including labeled monoclonal antibodies [9–11], activatable caspases [12], 
Affibody molecules [13, 14], nonobodies [15, 16], aptamers [17] and other proteins. It is 
likely that at least some of these agents will be in tomorrow’s operating room. Many of these 
probes will be labeled with fluorophores that re-emit light outside the visible spectrum. In an 
effort to reduce development costs or reduce saturation in vivo, some binding probes will be 
introduced to the patient in very small doses—termed “microdoses” [18, 19]—a strategy that 
also reduces the need for multispecies preclinical toxicology studies for federal approval, but 
necessitates the use of a highly sensitive camera for visualization. In other words, unlike the 
case of fluorescein sodium or ALA-induced PpIX, most new agents will not be directly 
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observable in the operating microscope because of the wavelength in the NIR or their use at 
lower concentrations. For these agents to impact patient outcome, they must be accurately 
visualized and properly integrated into the surgeon’s visual field. 
This type of image integration, often called an “image overlay” or “image fusion”, can be 
optimized through a deeper understanding of the process of human visual perception and the 
manner in which scalar information (e.g., fluorescence intensity) can be mapped to color 
space and integrated with the real or imaged field through transparency [20] or heads-up 
display [21]. The features affecting the success of this overlay and display process are 
reviewed here, with the goal of outlining procedures which have maximal benefit for surgical 
imaging in real time. 
 
Fig. 2. (A) The sensitivity of human photoreceptors for different wavelengths of light is shown 
(NB: the abscissa is defined according to a logarithmic scale). (B) The emission spectra of four 
common FGS fluorophores: fluorescein sodium (FS), protoporphyrin IX (PpIX), IRDye® 
800CW, and indocyanine green (ICG). (C) The CIE 1931 x,y chromaticity map showing the 
sRGB gamut used by most LED and LCD monitors, the trajectory of the exemplary color map 
(koufonisi), and the gamut representing brain tissue. The koufonisi colormap is perceptually 
balanced and has mid-high colors which circumscribe the brain tissue gamut, giving a uniform 
chromatic contrast. The average brain tissue gamut was characterized from intracranial images 
acquired from 10 patients, of which (D) is an example. 
2. Data visualization and visual perception in the surgical environment 
The goal of data visualization is to present numerical or categorical information in a format 
that enables efficient and accurate communication. In medical imaging, this is commonly 
done by mapping spatial distributions of scalar values to a color map representation or look up 
table (LUT). This enables visual interpretation of the scalars by the observer, since they can 
be converted back to their original scalar value on the basis of their color. In fluorescence-
guided surgery, the scalar function is most often emission intensity [22], fluorophore 
concentration [23], or more recently, receptor concentration [24, 25], and in the case of 
emission outside the visible spectrum, it is desirable to map this information onto a white-
light RGB or grayscale image through transparency blending. The exact manner in which 
values should be mapped to color and blended with the underlying image is a 
multidimensional problem. Elements of this problem space include a desire to maximize the 
efficiency of information transfer, while at the same time minimizing interpretive errors 
caused by perceptual artifacts. The framework should minimize loss-of-information due to the 
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limited dynamic range of the human visual system and concerns regarding the need for a 
clean, uncluttered aesthetic are tangible. To properly address these issues, it is helpful to 
review the anatomy of vision, including deficiencies such as deuteranopia and protanopia, and 
understand the relative perceptual features that make human vision, for example, more 
sensitive to luminance than hue. 
Processing and interpreting graphical data involves multiple levels of the human visual 
and perceptual system. The first step in the visual process involves the detection of photons 
by a collection of photoreceptor cells in the retina called cone and rod cells [26]. Upon 
interaction with an incident photon, a photochemical reaction occurs in a group of 
transmembrane receptors called opsins, which undergo conformational change, and 
communicate the detection of photons by neuronal firing to the visual cortex and other 
processing areas [27]. The human retina is comprised of cells with four different opsins: 
rhodopsin, which is expressed in rod cells and used in night vision, and three different 
photopsins known as short, medium and long wavelength sensitive, and have peak 
sensitivities at 420 nm, 534, and 564 nm, respectively (Fig. 2(A)). Rod cells are 1000x more 
sensitive to light than cone cells, contribute much more strongly to peripheral vision, and are 
about 20x more plentiful. Cone cells have much greater visual acuity, are sensitive to motion, 
and populate the central region of the fovea centralis. Fundamentally, these cells limit the 
perception of light to within the visible spectral range (400-700 nm). The spectral emission 
from an object is determined by the illuminant and the absorption and scattering by that 
object. Because the color of an object is influenced by the illuminant, the FDA introduced 
guidelines in 1998 encouraging adherence of surgical task lighting to standards defining total 
irradiance, central illuminance, correlated color temperature, and general color rendering. 
Indeed, surgical lighting has come a long way since the 19th century, when operating rooms 
in the northern hemisphere were built with southeast facing windows to maximize the natural 
lighting required for procedures to take place. The range of colors produced by absorption by 
tissue represents only a small gamut of the overall color space. Figure 2(C) shows the gamut 
determined from white-light cortical images acquired in 10 patients during craniotomy. 
Across subjects, the gamut is well conserved and occupies only 5% of the total perceivable 
color space: a limited dynamic range from which healthy tissue must be visually separated 
from malignant tissue. The impetus for fluorescence-based contrast is to provide an additional 
level of discrimination. 
The spectral sensitivity of the opsins convolved with the emission of light from the visual 
field is not sufficient to explain how color is perceived. Instead, it is more helpful to 
understand color in CIELAB: a perceptually-uniform, device-independent, basis for modeling 
human color perception. In this color space, all perceivable colors are defined according to 
lightness (L*), red/green (a*) and yellow/blue (b*). The human visual system is most 
sensitive to changes in lightness, and therefore, is considered the primary means by which to 
convey scalar information through color. Furthermore, discontinuities or inflection points in 
the L* dimension of a color map, for example when viewed using the pyramid test [28], has 
been identified as a major source of interpretive error when representing continuous data by 
color [29, 30]. 
When considering data visualization in a complex visual environment, it is important to 
understand the process of “attentive capture”: the directing of attention towards a subset of the 
larger visual environment so that it may be perceived in greater detail. The processes of visual 
attention are often divided into either goal-directed or stimulus-driven, based on whether it is 
deliberately deployed or a result of something which occurs unexpectedly within the subject’s 
visual field. Goal-directed capture, also known as “top-down”, is the principle mechanism in 
the intraoperative context, and it is modulated by experience and familiarity. Regions of tissue 
which have properties that are consistent with appearance of malignant tissue, based on 
previous experience, will be given the highest salience. The addition of fluorescence 
information introduces a perceptual dimension which will compete for attention, and the 
surgeon will direct her or his attention towards the perceptual dimension that is most 
important at achieving the current goal [31]. In fluorescence mode, areas of high intensity as 
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observed by visual fluorescence or through a graphical interface are likely to be given priority 
over low- or non-fluorescing regions. Therefore, resection of a series of cancer foci might 
occur in order of highest to lowest overall signal intensity. Another determinant is how much 
a given object differs from neighbouring objects within some given perceptual dimension 
[32]. For example, a color map representation of fluorescence which shows an area mapped as 
red, surrounded by an area mapped as green, may be given more attention than if it were 
surrounded by an area mapped as orange. A number of other factors will influence the 
attentive capture of objects including their distance from each other and any dynamic changes 
in intensity or spatial movement. Of particular importance to this review, work by Rock and 
Guttman demonstrate that it is possible to selectively attend to one of two objects which 
occupy the same spatial location, based on a unique perceptual dimension [33]. 
Given the complexity of the human visual system, there is unlikely to be a single “one-
size-fits-all” approach to parametric data visualization. Nevertheless, by applying the 
biological and neurophysiological concepts discussed in the preceding section, it is possible to 
make deliberate choices when attempting to display data in the intraoperative environment 
that will enhance clinical procedure. The remainder of the review will be a practical 
discussion of the decision-points typically encountered in fluorescence visualization. 
3. Color map visualization choices 
Given the complexity of human color perception, the selection of color map for the 
representation of scalar values represents a challenging task. Poor color map selection can 
lead to misrepresentation of reality; however, good color map selection can highlight 
clinically salient regions. Broadly speaking, there are three main types of color maps: 
sequential, diverging, and segmenting (also called qualitative or categorizing). These are 
depicted in Fig. 3. Sequential and diverging color maps are well-suited to displaying 
continuous scalar values: not surprisingly, these are the most common scalar representation 
systems encountered in medical imaging. Segmenting or categorizing color maps are used to 
depict discrete types of information such as numerical ranges and categories (e.g., WHO 
tumor grade index). When a natural order to the categories is present, such as an image 
segmented into its statistical quintiles, discretized versions of sequential or diverging color 
maps can be used. However, when no order is obvious, unordered nominal color maps are 
recommended [29]. There is a subcategory of sequential color maps, which would correctly 
be described as a “uniform color” or “constant-value” color map—whereby no scalar 
information is encoded by the chromaticity or luminosity, but rather the information is 
entirely conveyed by the transparency with respect to an underlying image. In other words, 
the alpha channel (α) is varied while R,G, and B are held constant. The manner in which 
transparency is used to blend scalar maps with the underlying image is dealt with separately in 
Section 4. 
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Fig. 3. (A) A representative sample of color maps used in medical imaging overlays (available 
in the OiM Overlay GUI), which include sequential, diverging, and categorical palettes. 
Examples of their use from literature include: (B) Doppler ultrasound image of placentia previa 
of blood flow using an opaquely-overlaid diverging hot/cold color map centered about a 
luminance nadir [34], (C) Axial fused PET/MR image, with FDG SUV values encoded by a 
hot color map and blended by a uniform transparency function [35], (D) Zeiss OPMI infrared 
800 blood flow module showing a pseudocolor representation of ICG wash-in delay during 
arteriovenous malformation [36], (E) the resection of a sentinel lymph node in laproscopic 
surgery detected using ICG [37]. 
It should be noted that the uniform color map is probably the most commonly used FGS 
literature [10, 38–48]. It is likely that the dominance of uniform color maps is largely 
attributable to their similarity to visible fluorescence emission actually observed, for example, 
when using ALA (Fig. 4(A), 4(F)), as well as the relative ease of overlaying single-channel 8-
bit images in image processing software such as ImageJ (NIH, Bethesda, MD). For uniform 
color maps, green is by far the most common color used for these overlays, likely because it is 
complimentary to the red hues present in the surgical cavity. Despite the popularity of the 
uniform green overlay scheme for visualization, there are several issues which make it 
suboptimal for intraoperative applications. While transparency enables the integration of 
information from the scalar map with the underlying white-light image, using the alpha 
channel as the only means of encoding scalar data in the image space is problematic when the 
underlying image varies in brightness. 
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Fig. 4. (A) The visual fluorescence emission from PpIX under blue light excitation on the Zeiss 
Pentero OPMI 800 surgical microscope during glioma resection, and (B) the RGB image 
acquired with white-light (~5500 K) illumination. (C) The PpIX concentration map recovered 
using hyperspectral imaging. (D) The [PpIX] is visualized using the multivariate koufonisi 
colormap and overlaid on the RGB image using the logistic function in (H) [max = 0.78, 
midpoint = 11.6 ug/ml, k = 11.8]. (E) The same information as in Panel C, but visualized using 
the myCarta cube1 color map (F) and as a single-value [RGB (7, 246, 64)] color map blended 
into the RGB image with the same transparency function (Panel H). (G) The 1931 CIE xy 
chromaticity plot showing the trajectories of the three color maps and the gamut from the RGB 
image. 
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In a recent review, Nguyen and Tsien state that one of the major factors limiting 
sensitivity of FGS is the presence of shadows with decreased excitation power, and pooling 
blood which absorbs emitted photons [49]. Near-infrared fluorophores may offer 
improvements in both these areas, as light in this spectral band penetrates tissue deeper and is 
absorbed less by blood [50]; however, these gains may be diminished if the information is 
subsequently obscured by the low brightness regions of the bottom image. Another problem 
with this visualization scheme is that it offers poor perceptual resolution—the ability to 
visually determine the scalar values represented by the overlay—compared with sequential 
and diverging color maps [29]. While some applications will undoubtedly desire to remove 
“anything that glows”, other applications may require the surgeon to integrate a threshold 
value of fluorescence against other visual cues such as texture, shape and color on the white-
light image. In either case, since no imaging agent provides “infinite” contrast with 
background, categorizing scalar information into either high probability or low probability of 
malignancy is a necessary step for successful application of FGS. Finally, the popularity of 
green uniform maps is of concern to the approximately 5% of the population that suffer from 
color vision deficiencies. In particular, the ability to distinguish between red and green may 
result in interpretive errors for those with deuteranopic and protanopic vision. 
 
Fig. 5. (A) Color map image overlay of quantitative fluorescence (qFI) during ALA-induced 
PpIX human glioma resection [51]. (B) Intensity image of folate conjugated to 
fluoresceinisothiocyanate (FITC), pseudocolored and overlaid onto an RGB image during 
ovarian cancer resection [52], (C) Pseudocolored ICG overlay during breast cancer lymph node 
resection [53] (D) Sentinal lymph node mapping of non-small cell lung cancer metastesis 
which has been pseudocolored and overlaid onto an RGB image intraoperatively [46]. 
The major requirements when choosing a color map for FGS are very similar to those in 
other applications of scientific visualization [29] and can be summarized as follows: 
1. Maximal perceptual resolution 
2. Minimal interference when blended with underlying shadows and 3D surfaces 
3. Perception of color map matches the underlying scalars. 
4. Maximal contrast with the color gamut represented in the bottom image. 
A perceptually balanced, evenly contrasting, and chromaticity varying color map such as 
koufinisi, is presented in Fig. 2(C), which appears to fit the needs well. Regarding luminance, 
a monotonically increasing color map is more intuitive than a diverging one, which has a 
maximum luminance in the center. Many such color maps have been described and published 
[30, 54], and some examples are presented in Fig. 3. Diverging color maps have the added 
benefit of doubling the perceptual resolution, since the full range of luminance is available on 
either side of the midpoint to encode scalar values, and together with the transparency 
function, can be modulated to highlight the clinical threshold if such a value has been defined. 
Within this range of options, the choice will be largely a personal one on the part of the 
surgeon—this should not introduce significant variability as long as balanced, contrasting 
color maps are selected, and objective transparency functions are used, which is the topic of 
the next section. 
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4. Transparency function or look-up table choices 
Appropriate blending of top and bottom images through transparency should augment the 
surgeon’s visual field with fluorescence information, and avoid introducing interpretive errors 
or obscuring the native information. The most basic information that the bottom image 
provides is context, so that the surgeon can safely navigate around anatomical features and 
approach suspicious areas with precision. Therefore, areas of low fluorescence information 
should be made transparent so that anatomical information is conveyed with the highest 
fidelity possible. Areas where fluorescence is extremely high—and associated with a 
correspondingly high positive predictive value—should be presented to the surgeon with high 
opacity, so that clinical decisions are weighted heavily towards this information. On these two 
aspects of transparency, there is wide agreement. How the bulk of the information in between 
these limits is blended is a matter of active debate. 
 
Fig. 6. The four transparency functions or look-up tables widely used in creating overlays. 
Three major functions are used to control the alpha channel of the top image (Fig. 6): 
uniform distribution, linear function, and power function. The uniform distribution is straight 
forward and commonly used in multimodal imaging such as PET/CT or PET/MRI [55]. A 
benefit of this approach is that it is straight-forward and unbiased. However, with respect to 
FGS, areas of uniform background fluorescence will cause a reduction in the dynamic range 
of the bottom image, resulting in loss of information. A linear function involves selecting two 
control points—a low point, below which uniform minimum opacity is applied, and a high 
point, above which a uniform maximum opacity is applied. In this regard, it mimics a 
standard window and leveling procedure. This is a common choice due to its simplicity in 
implementation. The third function has some similarities to the linear procedure, but in 
addition to high- and low- thresholds, it has an additional control point allowing the line 
between these points to be a curve defined by a power function. Also known as the gamma 
function approach (due to its similarity to the “gamma correction” procedure used to 
compensate for input-output characteristic of a cathode ray tube display), it is a popular 
choice in molecular imaging and is supported by most pre-clinical imaging systems for a 
simple reason: it is aesthetically pleasing. The additional control point provides a great deal of 
control over how the top image appears, and parameters can be adjusted arbitrarily to provide 
either a large, diffuse region of fluorescence information, or a small concentrated area of 
fluorescence information. If the goal is to localize a bioluminescence signal from a xenograft 
tumor with a reporter transfect, it is an ideal choice. However, in the context of FGS, it is 
dangerous: it introduces a large source of bias and obfuscates the surgical margin. 
Given the current practices in the field, there is significant room for improvement. We 
seek well-defined control points that enable the surgeon to identify and act on the clinical 
thresholds bringing about the greatest effect on patient outcome. To this end, we suggest a 
fourth function—the logistic function—which combines much of the functionality of the 
linear and power function approaches, but provides control points with statistical 
underpinnings. Let y(x) be the function which describes opacity as a function of x, the scalar 
values representing the min-max normalized top image: 
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Free parameters include L, the amplitude of the upper asymptote, k, which defines the 
maximum slope of the transition which is the derivative taken at x0, the mid-point of the 
transition between 0 and L. 
 
Fig. 7. The relationship between normal distributions of measured parameter values in normal 
and tumor regions, and the true positive rate (TPR) if that value was selected as the clinical 
threshold for diagnosis. The resulting TPR logistic function for (A) scarcely overlapping and 
(B) greatly overlapping distributions are shown. 
The benefit to using this formulation in comparison to the power function is that for 
applications involving FGS, the tumor probability function—the function mapping the 
continuous variable such as fluorophore concentration to the binary classifier (tumor vs. 
normal tissue)—also approximates a logistic function (Fig. 7) [56]. A probability function can 
be determined through clinical trials [57, 58], and then applied through the transparency 
function for future resections within a population representative of the sample group. The 
result is that the middle point of the function is made equal to the clinical threshold defining 
the boundary between positive and negative assignment, greatly facilitating the surgeons 
ability to perform the sort of visual ROC procedure which is implicitly required in FGS. 
Additionally, for an area of high positive predictive value, fluorescence information is 
automatically emphasized, and conversely, for an area of negative predictive value, 
fluorescence information is deemphasized, promoting prioritization of attentive capture based 
on other white-light image derived features, all while avoiding the introduction of bias 
normally associated with fusion and thresholding (Fig. 8). As a final point, such a function 
has the desirable result of being compatible with both sequential and diverging color maps, 
which achieve different goals in this context. Divergent color maps applied with this 
transparency function will help highlight the clinical threshold, and sequential color maps will 
exhibit a smoother blending of information from the bottom image so that in regions of low 
fluorescence, tumor probability is determined by other visual cues. 
 
Fig. 8. The same fluorescence map overlaid using a uniform colormap but with different 
transparency functions. (A) Logistic function with x = 5 μg/ml (B) logistic function with x = 10 
μg/ml, (D) linear function intersecting point (x = 14 μg/ml, y = 50%), (C) logistic function with 
x = 15 μg/ml. How the transparency function is defined will have large effects on the perceived 
margin of malignant tissue, highlighting the need for standardization. 
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5. Image compression choices 
A significant challenge for fluorescence-guided surgery is how to display a signal with high 
dynamic range (or bit-depth) in real-time. The traditional radiologic approach of window and 
level adjustment to maximize the display contrast may not be feasible quickly, and automated 
methods for display optimization are necessary. Fluorescence imaging display quality is a 
mixture of several features, and the detected intensity at the camera can vary by orders of 
magnitude within a scene. To compensate for undesirable background signals from tissue, 
non-linear components such as camera filters, and noise, many systems have shifted to high 
dynamic range cameras, so that simple removal or threshold can be applied to remove the 
background [59]. As camera bit-depths grow to accept 16-bit or higher bit-depth cameras and 
mainstream displays continue use 8-bits per channel, the problem of fluorescence intensity 
image representation and display is further compounded as images with large dynamic ranges 
of luminescence are now available. The value of image compression here will gain 
importance. This is obviously critical in areas where the real-time video stream is guiding the 
resection for tissue, such as with ALA-induced PpIX fluorescence imaging [7, 22, 60, 61] or 
with newer classes of molecular probes [44, 49, 62–64]. 
 
Fig. 9. Lymphatic uptake of fluorophore in a mouse is shown as the green overlay on grayscale 
white-light images. The leftmost column shows the original image and each subsequent 
column shows a processed image. Window-level adjustment with contrast-limited adaptive 
histogram equalization (CLAHE) was applied to the original images for comparison with log-
compressed images. Well plates with various concentrations of fluorophore ranging over 3 
orders of magnitude in concentration and fluorescence intensity are shown, and histograms 
corresponding to lymphatic uptake images. White arrows indicate a lymph vessel that is hard to 
detect at early time points without log compression. 5mm scale bars are shown. 
Dynamic range reduction of high-dynamic range (HDR) images [65], display 
optimization, and HDR display systems [66] are very active areas of research that have gained 
prominence within the computer vision and graphics communities in the last decade. Dynamic 
range-reduction of HDR images using automated mapping techniques is being explored [67] 
to provide automatic, fast, high-quality tone-mapping methods to improve quality of image 
display on devices with limited dynamic range. However, adaptation of such methods in 
display of fluorescence images has been limited, reflecting the nascence of high bit-depth 
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cameras in fluorescence imaging for surgical guidance, as opposed to pre-clinical imaging 
where off-line equalization methods are permissible. Mapping techniques that are free from 
user bias similar to logarithmic compression used in ultrasound displays [68] could potentially 
improve the availability of information to a surgeon especially in real-time imaging situations 
where features within a scene can span several orders of magnitude in intensity (Fig. 9). 
Similar to the case of transparency function, the goal is to create a bias-free, consistent and 
reproducible framework for visualization that will not introduce interpretive errors such as the 
over-interpretation of low signal. We anticipate that dynamic range compression will receive 
more attention the technological ability to capture bit-depth continues to gain distance on the 
human visual system’s ability to perceive it. 
6. Display hardware choices 
There is an active debate in the field of FGS as to which display hardware is best suited for 
visualizing fluorescence information: stand-alone monitor [39, 69] or microscope integrated 
heads-up display (HUD) [70]. More than simply user preference, studies have demonstrated 
that surgical task performance is influenced by location of image display devices [71] and the 
physical way in which the images are represented [72]. The answer may depend largely on the 
surgical application and the current workflow used for those procedures. For example, in 
sinus surgery, almost all procedures are performed using image-guided endoscopy, often 
through observation on a stand-alone monitor. It can therefore be expected that the addition of 
FGS data into this architecture would be of minimal burden. On the other hand, neurosurgical 
resection is principally done using operating microscopes. It would be highly desirable in this 
context to integrate FGS visualization into the actual ocular focal plane used by the surgeon, 
either by HUD or video feed. A hybrid option may well be the most viable solution: HUD 
visualization by contour (Fig. 10(B)) and stand-alone monitor visualization of a multivariate 
color map overlay (Fig. 4(D)). 
Heads-up display (HUD) is a visualization framework which displays information semi-
transparently so that the user isn’t required to divert attention from their present viewpoint. 
The term is borrowed from aviation, where it refers to a display that can be viewed while the 
pilot has their head positioned “up” and looking forward. In the context of an operating 
microscope, it enables the surgeon to view the information while keeping their head “down”, 
rather than having their head up to observe information on an auxiliary display monitor. These 
exist in two forms: integrated into the operating microscope eyepieces, or stand-alone in the 
form of eye ware [59, 73]. 
The case of an integrated configuration in the operating microscope (i.e., Zeiss 
MultiVision TM) a binary map is used to outline (Fig. 10(B)) or shade a region through 
hatching or dotting (Fig. 10(C)). In much the same way as the transparency function was 
informed by the tumor probability function in Section 4, the contours projected into the 
display could be determined by the clinical threshold, and additional contours, such as the line 
indicating values ± 10% from the clinical threshold, could be visualized by patterned lines or 
additional colors which is supported by many models. Traditionally, these have been viewed 
mainly to incorporate anatomical imaging into the planning and execution of a surgical 
procedure. For example, a surgeon might plan the location of an electrode implant using MRI, 
and then co-localize the locations of each electrode using the HUD. However, recent work has 
demonstrated their utility in visualizing ICG fluoresence [21]. 
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Fig. 10. (A) An early prototype of a HUD unit that was integrated into a clinical operating 
microscope allowing display of the augmented information into the surgeons microscope view. 
(B) An example contour representation of the data in Fig. 8 at threshold = 70%, showing the 
outline of the region for the surgeon. (C) A density point-cloud representation of the same data. 
Ongoing development in high dynamic-range and wide color gamut monitors, with 
accompanying software and operating system support, could have large implications for both 
data compression and color map visualization. Visual spectrum fluorophores such as PpIX 
emit fully saturated light, occupying the outermost region of the 1931 CIE chromaticity color 
space. When viewed under blue-light illumination the fuchsia-colored emission provides 
strong contrast with the background tissue that cannot be fully appreciated in the RGB image 
in Fig. 4(A). The ability to display a wider color gamut could extend this high-contrast 
imagery to color map representations of NIR fluorophores. 
6. Guidelines for effective surgical fluorescence visualization 
The following five conclusions have been determined based on the review of the literature 
highlighted in the preceding sections. Note that these are general guidelines applicable for 
many surgical applications; however, specific aspects of a procedure may require that 
modifications be made. 
I. Display inset images of top and bottom images alone 
- When viewed on an auxiliary monitor, the white-light only and fluorescence only 
images are ideally independently displayed. 
- When fed into the operating microscope, or used in a heads-up display framework, 
there should be a simple way to toggle between these three modes (WL, FLI, and 
composite) in real time. 
II. Select a univariate or multivariate perpetually-balanced color-map 
- Hue(s) should be selected based on their contrast to the surgical field and their 
compatibility with color vision deficiencies (Fig. 2(C)). 
- For multivariate color maps, scalar values should be encoded primarily by 
luminance. A second hue trajectory can be used to provide additional dynamic range 
when used in conjunction with a divergent luminance scheme. 
- For neurosurgery applications, we recommend the koufonisi color map, which is 
available for download as part of the OiM Overlay GUI. 
III. Map alpha to a known or estimated logistic function 
- The logistic function should be determined based on an estimated or measured 
threshold of tumor positivity. 
IV. Consider compression when actual dynamic range of camera is greater than 8-bit. 
- Logarithmic or other non-linear data compression should provide automated 
window and level adjustments for 14-bit and 16-bit information extending the range 
of information that can be simultaneously perceived. 
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V. Perform color vision deficiency, perception and display checks 
- To ensure maximum compatibility with the surgical team, a test for compatibility 
with deuteranopic and protanopic vision should be performed. 
- As an optional step, the Retinex model might be employed to test how an image 
luminance is being perceived due to other features present in the visual field. 
- The ability of the operating surgeon to easily test and make fine adjustments to the 
heads-up display during surgery is essential. 
7. OiM Overlay GUI: an open-source MATLAB overlay generator 
To facilitate the investigation and establishment of data visualization best practices, we have 
created an easy-to-use open-source MATLAB graphical user interface (GUI) (Fig. 11) that 
enables the user to overlay a scalar map over top of a white-light RGB or grayscale image. 
The GUI accepts a number of different imaging formats and MATLAB data structures—8-bit 
RGB images, DICOM, 14- and 16-bit TIFFs acquired with scientific cameras, *.mat data 
files, 22-bit LI-COR Pearl image sets—and enables the user to create an overlay through the 
selection of color map, transparency and other options. Additional file formats can be added 
in by users interested. 
 
Fig. 11. (A) Screenshot of the main window of Overlay GUI. A number of different sliders, 
radio-buttons and drop-down menus enable the user to quickly make fully customized color 
overlays, selecting from 18 different color maps and the four different transparency functions 
discussed in Section 4. (B) The normalized scalar magnitude vs. red, green and blue values as 
well as the lightness (L*) are shown for the present colormap (koufonisi) along with the 
Pyramid Test for lightness uniformity [28]. (C) The 1931 CIE x,y chromaticity plot showing 
the gamut for the current bottom image (contour plot overlay) and the trajectory of the current 
color map through the color space. 
At the time of this paper publication, the options for pseudocolor visualization of the top 
intensity image include multivariate colormaps (i.e., koufonisi, cube1, cubeYF, and patriotic, 
a divergent palette of red, white and blue). Univariate (i.e., transparency encoded) color maps 
can be selected by means of a color picker user interface, or by directly inputting the desired 
RGB values. The contour plot enables the user to overlay isobars of the intensity distribution 
with a solid color selected by means of the same color picker. Window and leveling can be 
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adjusted through the use of sliders, and intensity data can be visualized with log compression 
as well. 
Transparency LUTs are controlled by sliders and radio buttons: the type of function can be 
selected from logistic (default), power, linear or uniform. Free parameters modifying the 
shapes of these functions are subsequently selected using the sliders. The relationship between 
the opacity and the normalized intensity is plotted in real-time to inform the LUT selection. 
Analytical functions are provided as an additional feature of the application. These enable 
the user to gain a deeper understanding of how the various choices will impact the perception 
of the visualized data. Drop-down menu options include a comparison between the actual and 
perceived visually-encoded information using the Retinex model [74, 75], and diagrams of the 
available perceptually-balanced color maps such as koufonisi showing the color map 
trajectory and the white-light image color distributions plotted on a 1931 CIE luminosity 
diagram. Also included is a colorblindness simulator enabling the user to view the overlay as 
it would be perceived with deuteranopic and protanopic vision. The source code, as well as 
the most current stable release can be found at http://dartmouth.edu/~overlay . 
8. Conclusion 
Adoption of fluorescence guided surgery is facilitated by employing visualization strategies 
that maximize the information provided by fluorescence while minimizing disruption to the 
visual field or changes to the clinical workflow. When considering the importance of non-
visible fluorophores (either spectrally near-infrared, or because they are administered in low 
doses), image overlays—via both LED monitor display units and operating microscope heads-
up display—will provide the primary means of conveying fluorescence parameters. Effective 
image overlays depend mainly on the selection of color map and transparency functions, 
which should be intentional and unbiased by customized thresholding or light balance. To 
facilitate the exploration and adherence to standards of best practice, we provide an open-
source MATLAB based tool that can be downloaded free of charge. 
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